Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents
Open Access
- 20 July 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (56) , 30773-30786
Abstract
Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agentsKeywords
This publication has 50 references indexed in Scilit:
- CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex VivoJournal of Cancer, 2013
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- The phenotype of FancB-mutant mouse embryonic stem cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- PALB2 is an integral component of the BRCA complex required for homologous recombination repairProceedings of the National Academy of Sciences, 2009
- Nucleoside analogs: molecular mechanisms signaling cell deathOncogene, 2008
- DNA Damage and Repair: From Molecular Mechanisms to Health ImplicationsAntioxidants & Redox Signaling, 2008
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancerCancer, 2008
- Regulation of DNA repair throughout the cell cycleNature Reviews Molecular Cell Biology, 2008
- Functional Analysis of the Four DNA Binding Domains of Replication Protein AJournal of Biological Chemistry, 2001
- Role of poly(ADP-ribose) formation in DNA repairNature, 1992